Bioatla Cash And Cash Equivalents Changes vs Change To Operating Activities Analysis
BCAB Stock | USD 1.55 0.06 3.73% |
Bioatla financial indicator trend analysis is way more than just evaluating Bioatla prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bioatla is a good investment. Please check the relationship between Bioatla Cash And Cash Equivalents Changes and its Change To Operating Activities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.
Cash And Cash Equivalents Changes vs Change To Operating Activities
Cash And Cash Equivalents Changes vs Change To Operating Activities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bioatla Cash And Cash Equivalents Changes account and Change To Operating Activities. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Bioatla's Cash And Cash Equivalents Changes and Change To Operating Activities is 0.92. Overlapping area represents the amount of variation of Cash And Cash Equivalents Changes that can explain the historical movement of Change To Operating Activities in the same time period over historical financial statements of Bioatla, assuming nothing else is changed. The correlation between historical values of Bioatla's Cash And Cash Equivalents Changes and Change To Operating Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Cash Equivalents Changes of Bioatla are associated (or correlated) with its Change To Operating Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Operating Activities has no effect on the direction of Cash And Cash Equivalents Changes i.e., Bioatla's Cash And Cash Equivalents Changes and Change To Operating Activities go up and down completely randomly.
Correlation Coefficient | 0.92 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Cash And Cash Equivalents Changes
Change To Operating Activities
Most indicators from Bioatla's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bioatla current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.The current year's Sales General And Administrative To Revenue is expected to grow to 145.21, whereas Selling General Administrative is forecasted to decline to about 22.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 1.3M | 1.2M | 1.2M | 1.2M | Interest Income | 350K | 1.6M | 5.7M | 6.0M |
Bioatla fundamental ratios Correlations
Click cells to compare fundamentals
Bioatla Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bioatla fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.3M | 244.9M | 254.4M | 225.7M | 119.7M | 159.6M | |
Short Long Term Debt Total | 18.1M | 682K | 5.4M | 4.0M | 2.5M | 2.3M | |
Other Current Liab | 10.5M | 10.0M | 15.9M | 15.9M | 21.3M | 14.8M | |
Total Current Liabilities | 26.7M | 32.3M | 19.8M | 23.1M | 28.3M | 25.6M | |
Total Stockholder Equity | (56.0M) | 210.0M | 210.8M | 180.3M | 70.7M | 107.7M | |
Net Tangible Assets | (145.3M) | 210.0M | 210.8M | 180.3M | 207.4M | 217.8M | |
Property Plant And Equipment Net | 4.7M | 4.1M | 7.0M | 5.2M | 3.1M | 5.1M | |
Net Debt | 14.4M | (237.9M) | (239.6M) | (211.5M) | (109.0M) | (114.5M) | |
Retained Earnings | (148.4M) | (90.9M) | (186.3M) | (292.8M) | (416.3M) | (395.4M) | |
Accounts Payable | 5.1M | 2.5M | 1.2M | 4.2M | 3.8M | 3.4M | |
Cash | 3.7M | 238.6M | 245.0M | 215.5M | 111.5M | 151.3M | |
Non Current Assets Total | 4.8M | 4.3M | 7.1M | 5.3M | 3.3M | 5.3M | |
Cash And Short Term Investments | 3.7M | 238.6M | 245.0M | 215.5M | 111.5M | 151.3M | |
Liabilities And Stockholders Equity | 9.3M | 244.9M | 254.4M | 225.7M | 119.7M | 159.6M | |
Non Current Liabilities Total | 38.6M | 2.7M | 23.8M | 22.3M | 20.6M | 19.2M | |
Other Current Assets | 214K | 2.1M | 2.3M | 4.9M | 9.6M | 10.0M | |
Other Stockholder Equity | 2.3M | 300.9M | 397.1M | 473.1M | 486.9M | 304.7M | |
Total Liab | 65.3M | 35.0M | 43.6M | 45.4M | 49.0M | 37.8M | |
Net Invested Capital | (127.2M) | 210.7M | 210.8M | 180.3M | 70.7M | 81.1M | |
Property Plant And Equipment Gross | 4.7M | 4.1M | 11.2M | 10.5M | 9.2M | 8.0M | |
Total Current Assets | 4.5M | 240.7M | 247.3M | 220.4M | 116.4M | 154.4M | |
Net Working Capital | (22.2M) | 208.4M | 227.5M | 197.3M | 88.1M | 128.8M | |
Property Plant Equipment | 4.7M | 4.1M | 7.0M | 2.7M | 3.1M | 4.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.70) | Revenue Per Share 0.228 | Quarterly Revenue Growth 0.316 | Return On Assets (0.50) | Return On Equity (1.39) |
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.